Ny forside

We’re Here To Solve Your Biggest Protein Challenges

We are a team of highly experienced scientists specialised in protein development; developing cell lines and processes based on a non-viral Drosophila S2 cells expression system.
We are driven by a very focused passion for helping our partners solve their most critical and unique recombinant protein challenges.
Our stable and flexible ExpreS2 recombinant protein expression platform perfectly supports all phases of drug discovery, R&D and manufacturing.


Can-Do is more than just an attitude

At ExpreS2ion Biotechnologies, we are driven by the idea that we can solve uniquely difficult protein challenges that no one else can.
We are immensely proud of our unique ExpreS2 platform and the value it can bring to the world of biopharmaceuticals.

That’s why when you work with us, you experience a group of highly engaged collaborators, eager to take on your protein challenge as our own.
We work to quickly, efficiently and cost-effectively provide the proteins you need, with the right quality, when you need them.

Get in touch with anyone on our management team to hear more about how we work.

Latest publications by Expres2ion Biotechnologies

Proof of concept in animals for a new potential breakthrough malaria vaccine

An effective vaccine is a priority for malaria control and elimination. The leading candidate in the Plasmodium falciparum blood stage ...
Read More
/ Publications

Structure of Plasmodium falciparum Rh5–CyRPA–Ripr invasion complex

Plasmodium falciparum causes the severe form of malaria that has high levels of mortality in humans. Blood-stage merozoites of P. falciparuminvade erythrocytes, ...
Read More
/ Publications

Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody

The quest to develop an effective malaria vaccine remains a major priority in the fight against global infectious disease. An ...
Read More
/ Publications

Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells

Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) is a leading asexual blood-stage vaccine candidate for malaria. In preparation for clinical ...
Read More
/ Publications
protein development